Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

FDA grants breakthrough therapy designation to vonapanitase from Proteon Therapeutics

May 11, 2017

Nymox seeks approval of fexapotide triflutate for BPH in five European countries

May 4, 2017

Aurinia outlines phase III plans for voclosporin in lupus nephritis

April 7, 2017

Sentien Biotechnologies closes series A financing to fund development of SBI-101

April 6, 2017

Monash University identifies novel drug conjugates

March 31, 2017

Omeros reports further data from phase II trial of OMS-721 in serious kidney disorders

March 31, 2017

Tadalafil shows efficacy in the treatment of Peyronie's disease

March 29, 2017

KPR-2579, a novel TRPM8 antagonist for the potential treatment of bladder hypersensitivity

March 28, 2017

FDA grants orphan drug designation to avacopan for C3 glomerulopathy

March 23, 2017

Sunshine Lake Pharma identifies urate transporter 1/xanthine oxidase inhibitors

March 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...